GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Date Action Amount Person Type
Apr 05, 2024 Buy 0 Vultaggio Vincent Common Stock
Apr 05, 2024 Buy 12 500 Vultaggio Vincent Stock Option (Right to Buy)
Apr 05, 2024 Buy 10 000 Vultaggio Vincent Stock Option (Right to Buy)
Apr 05, 2024 Buy 6 875 Vultaggio Vincent Stock Option (Right to Buy)
Apr 05, 2024 Buy 2 750 Vultaggio Vincent Stock Option (Right to Buy)
Apr 05, 2024 Buy 17 500 Vultaggio Vincent Stock Option (Right to Buy)
Apr 05, 2024 Buy 25 000 Vultaggio Vincent Stock Option (Right to Buy)
Feb 12, 2024 Sell 2 573 Epperly Melissa B, Common Stock
Feb 12, 2024 Sell 1 173 Gallagher Cam Common Stock
Feb 02, 2024 Sell 1 585 Lackner Mark Common Stock
Feb 02, 2024 Sell 3 310 Paul Andrea Common Stock
Feb 02, 2024 Sell 11 552 Gallagher Cam Common Stock
Feb 02, 2024 Sell 8 669 Epperly Melissa B, Common Stock
Feb 01, 2024 Buy 337 500 Hausman Diana Common Stock
Feb 01, 2024 Buy 337 500 Hausman Diana Stock Option (Right to Buy)
Feb 01, 2024 Buy 141 000 Lackner Mark Common Stock
Feb 01, 2024 Buy 141 000 Lackner Mark Stock Option (Right to Buy)
Feb 01, 2024 Buy 112 500 Paul Andrea Common Stock
Feb 01, 2024 Buy 112 500 Paul Andrea Stock Option (Right to Buy)
Feb 01, 2024 Buy 90 000 Paul Andrea Stock Option (Right to Buy)
Feb 01, 2024 Buy 192 500 Gallagher Cam Common Stock
Feb 01, 2024 Buy 192 500 Gallagher Cam Stock Option (Right to Buy)
Feb 01, 2024 Buy 75 000 Epperly Melissa B, Common Stock
Feb 01, 2024 Buy 75 000 Epperly Melissa B, Stock Option (Right to Buy)
Feb 01, 2024 Buy 250 000 Blackwell Kimberly Common Stock
Feb 01, 2024 Sell 20 655 Blackwell Kimberly Common Stock
Feb 01, 2024 Buy 250 000 Blackwell Kimberly Stock Option (Right to Buy)
Jan 02, 2024 Buy 60 000 Lackner Mark Stock Option (Right to Buy)
Jan 02, 2024 Buy 40 000 Lackner Mark Common Stock
Dec 31, 2023 Buy 0 Lackner Mark Common Stock
Dec 31, 2023 Buy 215 000 Lackner Mark Stock Option (Right to Buy)
Dec 31, 2023 Buy 23 687 Lackner Mark Stock Option (Right to Buy)
Dec 20, 2023 Sell 24 158 Bunker Kevin D. Common Stock
Nov 13, 2023 Buy 5 000 Blackwell Kimberly Common Stock
Nov 10, 2023 Buy 17 000 Johnson David Michael Common Stock
Oct 04, 2023 Sell 8 906 Brownstein Carrie Common Stock
Oct 04, 2023 Sell 1 722 Brownstein Carrie Common Stock
Oct 04, 2023 Sell 5 085 Bunker Kevin D. Common Stock
Oct 04, 2023 Sell 983 Bunker Kevin D. Common Stock
Oct 04, 2023 Sell 4 594 Epperly Melissa B, Common Stock
Oct 04, 2023 Sell 888 Epperly Melissa B, Common Stock
Sep 11, 2023 Sell 5 000 Skvarka Jan Common Stock
Jun 20, 2023 Buy 4 760 000 Matrix Capital Management Company, Lp Common Stock, par value $0.001 per share
Jun 16, 2023 Buy 19 059 Johnson David Michael Common Stock
Jun 16, 2023 Buy 16 364 Kariuki Enoch Common Stock
Jun 16, 2023 Buy 16 364 Skvarka Jan Common Stock
May 31, 2023 Sell 9 242 Gallagher Cam Common Stock
May 31, 2023 Sell 18 526 Gallagher Cam Common Stock
May 26, 2023 Sell 80 000 Bunker Kevin D. Common Stock
May 08, 2023 Buy 39 732 Hausman Diana Common Stock
May 08, 2023 Buy 0 Hausman Diana
Mar 01, 2023 Buy 297 500 Roth Iris Stock Option (Right to Buy)
Mar 01, 2023 Buy 52 500 Roth Iris Common Stock
Feb 14, 2023 Sell 5 227 Epperly Melissa B, Common Stock
Feb 14, 2023 Sell 8 501 Gallagher Cam Common Stock
Feb 14, 2023 Sell 6 500 Bunker Kevin D. Common Stock
Feb 13, 2023 Sell 2 624 Epperly Melissa B, Common Stock
Feb 13, 2023 Sell 3 332 Gallagher Cam Common Stock
Feb 13, 2023 Sell 3 807 Bunker Kevin D. Common Stock
Feb 13, 2023 Buy 0 Roth Iris
Feb 06, 2023 Sell 9 428 Gallagher Cam Common Stock
Feb 06, 2023 Sell 572 Gallagher Cam Common Stock
Feb 01, 2023 Buy 91 354 Bunker Kevin D. Common Stock
Feb 01, 2023 Buy 132 646 Bunker Kevin D. Stock Option (Right to Buy)
Feb 01, 2023 Buy 161 092 Gallagher Cam Common Stock
Feb 01, 2023 Buy 233 908 Gallagher Cam Stock Option (Right to Buy)
Feb 01, 2023 Buy 355 200 Blackwell Kimberly Stock Option (Right to Buy)
Feb 01, 2023 Buy 244 800 Blackwell Kimberly Common Stock
Feb 01, 2023 Buy 101 957 Epperly Melissa B, Common Stock
Feb 01, 2023 Buy 148 043 Epperly Melissa B, Stock Option (Right to Buy)
Feb 01, 2023 Buy 59 217 Paul Andrea Stock Option (Right to Buy)
Feb 01, 2023 Buy 40 783 Paul Andrea Common Stock
Feb 01, 2023 Buy 16 313 Brownstein Carrie Common Stock
Feb 01, 2023 Buy 23 687 Brownstein Carrie Stock Option (Right to Buy)
Jan 17, 2023 Sell 9 500 Gallagher Cam Common Stock
Jan 17, 2023 Sell 500 Gallagher Cam Common Stock
Jan 05, 2023 Sell 9 700 Gallagher Cam Common Stock
Jan 05, 2023 Sell 300 Gallagher Cam Common Stock
Nov 15, 2022 Sell 11 600 Gallagher Cam Common Stock
Nov 15, 2022 Sell 900 Gallagher Cam Common Stock
Nov 09, 2022 Sell 30 000 Bunker Kevin D. Common Stock
Nov 08, 2022 Sell 12 374 Gallagher Cam Common Stock
Nov 07, 2022 Sell 12 343 Gallagher Cam Common Stock
Nov 07, 2022 Sell 157 Gallagher Cam Common Stock
Oct 17, 2022 Sell 12 500 Gallagher Cam Common Stock
Oct 06, 2022 Sell 10 000 Gallagher Cam Common Stock
Oct 05, 2022 Sell 7 004 Gallagher Cam Common Stock
Oct 05, 2022 Sell 5 496 Gallagher Cam Common Stock
Oct 03, 2022 Buy 50 000 Epperly Melissa B, Common Stock
Oct 03, 2022 Buy 50 000 Bunker Kevin D. Common Stock
Oct 03, 2022 Buy 50 000 Bunker Kevin D. Stock Option (Right to Buy)
Oct 03, 2022 Buy 300 000 Brownstein Carrie Stock Option (Right to Buy)
Oct 03, 2022 Buy 100 000 Brownstein Carrie Stock Option (Right to Buy)
Sep 16, 2022 Sell 8 866 Gallagher Cam Common Stock
Sep 16, 2022 Sell 1 134 Gallagher Cam Common Stock
Sep 15, 2022 Sell 8 426 Gallagher Cam Common Stock
Sep 15, 2022 Sell 4 074 Gallagher Cam Common Stock
Sep 09, 2022 Buy 36 606 Skvarka Jan Common Stock
Sep 09, 2022 Buy 0 Skvarka Jan
Aug 10, 2022 Sell 5 000 Bunker Kevin D. Common Stock
INSIDER POWER
91.810
Last 100 transactions
Buy: 10 139 437 | Sell: 398 486 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 91.810.

In total, the insiders bought 10 139 437 and sold 398 486 ZNTL shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT